Page last updated: 2024-10-27

fenofibrate and Tachycardia, Ventricular

fenofibrate has been researched along with Tachycardia, Ventricular in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
"Fenofibrate is a peroxisome proliferator-activated receptor (PPAR)-α activator that lowers triglycerides and influences cytochrome P-450 (CYP-450) epoxygenase-dependent arachidonic acid (AA) metabolism."1.48Protective effect of fenofibrate against ischemia-/reperfusion-induced cardiac arrhythmias in isolated rat hearts. ( Al-Masri, AA; Almotrefi, AA; Bukhari, IA; Mohamed, OY; Sheikh, SA, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bukhari, IA1
Almotrefi, AA1
Mohamed, OY1
Al-Masri, AA1
Sheikh, SA1

Other Studies

1 other study available for fenofibrate and Tachycardia, Ventricular

ArticleYear
Protective effect of fenofibrate against ischemia-/reperfusion-induced cardiac arrhythmias in isolated rat hearts.
    Fundamental & clinical pharmacology, 2018, Volume: 32, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Diltiazem; Disease Models, Animal; Fenofibrate; Heart Rate; Isolate

2018